Testing effectiveness (Phase 2)UnknownNCT05969158
What this trial is testing
Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma
Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Sun Yat-sen University 90